While the test is still in the development phase, it demonstrates the promise of blood-based early cancer detection, a technology that could revolutionize screening and diagnostic practices.

A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance ...

Current methods for cancer diagnosis are based on identifying biomarkers - molecules that reveal a particular state or ...

In a proof-of-concept study, the team used machine learning to analyze blood plasma from more than 2,000 participants and link molecular patterns to lung cancer, extrapolating a potential ...

Putting PAC-MANN to the test The team validated the test using blood samples from 110 patients with pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.

Half were later diagnosed with cancer within six months of giving blood. The rest stayed cancer-free. The researchers ran the samples through a multicancer early detection (MCED) test, which uses ...

Learn about Galleri, the multi-cancer early detection blood test. Understand how it screens for 50+ cancers using cfDNA, its accuracy, cost, and limitations.

Lung cancer accounts for 1 in 5 cancer-related deaths in the United States. While doctors say lung cancer is often treatable if caught early, millions of Americans who should be getting screened for ...

OXcan's multidisciplinary team is developing a new generation of liquid biopsy blood tests using cutting-edge proteomics and explainable machine learning approaches that can detect the deadliest ...